The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain
about
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancyBeneficial effects of estrogen in a mouse model of cerebrovascular insufficiencyThe creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine depositsCyclocreatine treatment improves cognition in mice with creatine transporter deficiencyDevelopmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.γ-Aminobutyric acid transporter 2 mediates the hepatic uptake of guanidinoacetate, the creatine biosynthetic precursor, in rats.Creatine metabolism differs between mammals and rainbow trout (Oncorhynchus mykiss).In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism.Stuck at the bench: Potential natural neuroprotective compounds for concussion.An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies.Mechanisms of the penetration of blood-borne substances into the brain.Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult.Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?Solute Carriers in the Blood-Brain Barier: Safety in Abundance.Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic miceAxonal and glial microstructural information obtained with diffusion-weighted magnetic resonance spectroscopy at 7T.Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices.Creatine transporter localization in developing and adult retina: importance of creatine to retinal function.Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain.Creatine uptake in brain and skeletal muscle of mice lacking guanidinoacetate methyltransferase assessed by magnetic resonance spectroscopy.Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake.Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells.Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity.Two novel mutations in SLC6A8 cause creatine transporter defect and distinctive X-linked mental retardation in two unrelated Dutch families.Absolute Oral Bioavailability of Creatine Monohydrate in Rats: Debunking a Myth.
P2860
Q24631151-0724B066-067D-443E-8229-BD7EA884FD5CQ24811264-57EB4FD3-A818-48CB-A6DB-ACAE3E23C1D1Q27006952-AC3EDD89-E094-47DB-B058-E199469D3241Q27349876-8A4D4EAB-38A2-476C-85C6-26C5F20000BBQ28200789-5FFBCC4D-5C11-4602-97E7-5A15BE081611Q30523794-D68C5EA7-2131-47EB-A8D8-5CB9DB3E2A0CQ33477139-61DF4769-F94C-43A1-98C5-28A9EB7D2193Q33648688-CC60D3F1-086D-4A06-B783-34589B13F731Q33729818-8D35FA30-CA52-4043-8FD3-36C6C7473808Q34182787-69539BA4-7669-4B0E-AC6B-356828D3FE00Q34206841-5D647E3F-AFB4-4C01-98DA-0A3701573A41Q34247638-BC6F01CA-F432-4B36-8D74-7C9A48D30DE3Q35493114-D24E119F-BF62-4F62-B971-DC335CE91269Q36597762-43F232A1-8DAE-428E-8ECB-DEA75AE75985Q37313443-DEBA6E67-A2B0-4BCB-B27F-B18341F27723Q37817010-4F63DDBD-9F84-48CB-9689-A9753E05DB53Q37847248-D6DBF2DC-53C4-4F09-B482-F1387A662419Q38706110-3963E25E-9376-45DD-BFCC-1D4EFF4222D6Q38727725-98662813-5EF4-41A6-AE6F-73AD271C8FF7Q38922312-B8A80871-E95E-4E32-B25A-FA1C90CD8F78Q40436889-349C35CE-E6CF-4723-A524-97F1C482E135Q41215893-5CCD3B1D-10B1-41A2-8375-BFD9574606AEQ44537154-F1166970-C430-48CA-A234-16419BA4E722Q46522477-85CB3F4D-9086-4570-B617-3A3BB5058416Q47930663-82CE7571-FD58-472D-96CD-B831FC923C73Q48249488-8FA6FB1F-892E-4D70-9236-7CCADBEF7AB4Q48306461-A68E7B18-DC8F-4E3D-8604-699DDF4ABD37Q48379286-580EA8C6-E12E-4771-8144-1C97AC85A32BQ48583660-E8A1F1E7-5ED5-4020-81FB-A22642AD3A76Q51933512-E98AD30A-D331-416E-A246-CD2AC61FCD95Q55069818-F8D7FAAB-265B-4B4C-AC07-646998A7C0F3
P2860
The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain
description
im November 2002 veröffentlicher wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2002
@uk
name
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@en
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@nl
type
label
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@en
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@nl
prefLabel
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@en
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@nl
P2093
P2860
P1476
The Blood–Brain Barrier Creati ...... upplying Creatine to the Brain
@en
P2093
Hidemi Shimizu
Hitomi Takanaga
Ken-ichi Hosoya
Masahiko Watanabe
Masanori Tachikawa
Tetsuya Terasaki
P2860
P304
P356
10.1097/01.WCB.0000033966.83623.7D
P577
2002-11-01T00:00:00Z
P6179
1027607096